Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 22 Issue: 3 Year: 2022 Page: 318-327 Author(s): Xiao-Hu Liu,Shi-Zhong Cai,Yue Zhou,Ya-Ping Wang,Yan-Jun Han,Cui-Li Wang,Wen Zhou
Journal: Current Pharmaceutical Design Volume: 17 Issue: 2 Year: 2011 Page: 2278-2289 Author(s): Shin-Wei Wang, Jiag-Ki Lee, Chia-Chen Ku, Shyh-Shin Chiou, Chen-Lung Steve Lin, Ming-Feng Ho, Deng-Chyang Wu, Kazunari K. Yokoyama
Journal: Reviews on Recent Clinical Trials Volume: 2 Issue: 3 Year: 2007 Page: 217-236 Author(s): Diego F. Calvisi, Rosa M. Pascale, Francesco Feo
Journal: Current Pharmaceutical Design Volume: 19 Issue: 8 Year: 2013 Page: 1371-1378 Author(s): Deborah French,Laura Lorenzon
Journal: Current Pharmaceutical Design Volume: 22 Issue: 37 Year: 2016 Page: 5730-5737 Author(s): Amir Tajbakhsh,Mohammad Sadegh Khorrami,Seyed Mahdi Hassanian,Malihe Aghasizade,Alireza Pasdar,Mina Maftouh,Ehsan Tabatabai,Seyed Mohammad Reza Parizadeh,Mostafa Fazeli,Gordon A. Ferns,Majid Ghayour-Mobarhan,Amir Avan
Journal: Current Pharmaceutical Design Volume: 20 Issue: 33 Year: 2014 Page: 5246-5259 Author(s): Eyal Greenberg,Yael Nemlich,Gal Markel
Journal: Current Cancer Therapy Reviews Volume: 2 Issue: 3 Year: 2006 Page: 271-279 Author(s): Yong Wang, Virginia Probin, Daohong Zhou
Journal: Current Pharmaceutical Design Volume: 19 Issue: 8 Year: 2013 Page: 1358-1370 Author(s): Miriam Reuschenbach,Magnus von Knebel Doeberitz
Journal: Current Molecular Medicine Volume: 6 Issue: 7 Year: 2006 Page: 731-738 Author(s): David G. Johnson, James DeGregori
Journal: Current Molecular Pharmacology Volume: 2 Issue: 2 Year: 2009 Page: 149-160 Author(s): Zhenlong Wu, Qiang Yu
Previous Next